234 related articles for article (PubMed ID: 34127355)
1. Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19.
Hasegawa T; Nakagawa A; Suzuki K; Yamashita K; Yamashita S; Iwanaga N; Tamada E; Noda K; Tomii K
Cytokine; 2021 Dec; 148():155618. PubMed ID: 34127355
[TBL] [Abstract][Full Text] [Related]
2. The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
Copaescu A; James F; Mouhtouris E; Vogrin S; Smibert OC; Gordon CL; Drewett G; Holmes NE; Trubiano JA
Front Immunol; 2021; 12():646095. PubMed ID: 33815405
[TBL] [Abstract][Full Text] [Related]
3. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
[TBL] [Abstract][Full Text] [Related]
4. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
Front Immunol; 2021; 12():691879. PubMed ID: 34163488
[TBL] [Abstract][Full Text] [Related]
5. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
Michalski JE; Kurche JS; Schwartz DA
Transl Res; 2022 Mar; 241():13-24. PubMed ID: 34547499
[TBL] [Abstract][Full Text] [Related]
6. Th1 cytokine endotype discriminates and predicts severe complications in COVID-19.
Hasegawa T; Hato T; Okayama T; Ikeo K; Miyamoto Y; Iwanaga N; Suzuki K; Yoshida M; Yamashita K; Yamashita S; Tamada E; Khasawneh A; Paran FJ; Oyama R; Naito T; Noda K; Tabe Y
Eur Cytokine Netw; 2022 Jun; 33(2):25-36. PubMed ID: 36266985
[TBL] [Abstract][Full Text] [Related]
7. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients.
Hoechter DJ; Becker-Pennrich A; Langrehr J; Bruegel M; Zwissler B; Schaefer S; Spannagl M; Hinske LC; Zoller M
Thromb Res; 2020 Dec; 196():186-192. PubMed ID: 32891904
[TBL] [Abstract][Full Text] [Related]
8. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
9. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.
Hue S; Beldi-Ferchiou A; Bendib I; Surenaud M; Fourati S; Frapard T; Rivoal S; Razazi K; Carteaux G; Delfau-Larue MH; Mekontso-Dessap A; Audureau E; de Prost N
Am J Respir Crit Care Med; 2020 Dec; 202(11):1509-1519. PubMed ID: 32866033
[No Abstract] [Full Text] [Related]
10. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
[TBL] [Abstract][Full Text] [Related]
11. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target.
Ntatsoulis K; Karampitsakos T; Tsitoura E; Stylianaki EA; Matralis AN; Tzouvelekis A; Antoniou K; Aidinis V
Front Immunol; 2021; 12():687397. PubMed ID: 34671341
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.
Quartuccio L; Fabris M; Sonaglia A; Peghin M; Domenis R; Cifù A; Curcio F; Tascini C
Cytokine; 2021 Apr; 140():155438. PubMed ID: 33493861
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the lipid profile associate with a dysregulated inflammatory, prothrombotic, anti-fibrinolytic state and development of severe acute kidney injury in coronavirus disease 2019 (COVID-19): A study from Cincinnati, USA.
Henry BM; Szergyuk I; de Oliveira MHS; Abosamak MF; Benoit SW; Benoit JL; Lippi G
Diabetes Metab Syndr; 2021; 15(3):863-868. PubMed ID: 33878674
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
Norooznezhad AH; Mansouri K
Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
[TBL] [Abstract][Full Text] [Related]
15. Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability.
Kovacs-Kasa A; Zaied AA; Leanhart S; Koseoglu M; Sridhar S; Lucas R; Fulton DJ; Vazquez JA; Annex BH
Microbiol Spectr; 2022 Feb; 10(1):e0167121. PubMed ID: 35171047
[TBL] [Abstract][Full Text] [Related]
16. Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome.
Metkus TS; Sokoll LJ; Barth AS; Czarny MJ; Hays AG; Lowenstein CJ; Michos ED; Nolley EP; Post WS; Resar JR; Thiemann DR; Trost JC; Hasan RK
Circulation; 2021 Feb; 143(6):553-565. PubMed ID: 33186055
[TBL] [Abstract][Full Text] [Related]
17. Predicting respiratory failure in patients infected by SARS-CoV-2 by admission sex-specific biomarkers.
Pagano MT; Peruzzu D; Busani L; Pierdominici M; Ruggieri A; Antinori A; D'Offizi G; Petrosillo N; Palmieri F; Piselli P; Cicalini S; Notari S; Nicastri E; Agrati C; Ippolito G; Vaia F; Gagliardi MC; Capobianchi MR; Ortona E;
Biol Sex Differ; 2021 Nov; 12(1):63. PubMed ID: 34809704
[TBL] [Abstract][Full Text] [Related]
18. Cytokine signatures of end organ injury in COVID-19.
Gómez-Escobar LG; Hoffman KL; Choi JJ; Borczuk A; Salvatore S; Alvarez-Mulett SL; Galvan MD; Zhao Z; Racine-Brzostek SE; Yang HS; Stout-Delgado HW; Choi ME; Choi AMK; Cho SJ; Schenck EJ
Sci Rep; 2021 Jun; 11(1):12606. PubMed ID: 34131192
[TBL] [Abstract][Full Text] [Related]
19. Critical roles of cytokine storm and secondary bacterial infection in acute kidney injury development in COVID-19: A multi-center retrospective cohort study.
Li XQ; Liu H; Meng Y; Yin HY; Gao WY; Yang X; Xu DS; Cai XD; Guan Y; Lerman LO; Peng ZY; Zhou HR
J Med Virol; 2021 Dec; 93(12):6641-6652. PubMed ID: 34314040
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 infection: an overview on cytokine storm and related interventions.
Montazersaheb S; Hosseiniyan Khatibi SM; Hejazi MS; Tarhriz V; Farjami A; Ghasemian Sorbeni F; Farahzadi R; Ghasemnejad T
Virol J; 2022 May; 19(1):92. PubMed ID: 35619180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
